• Labcorp entered a research collaboration with the FDA and Charles River Laboratories to improve methods for evaluating medicines' abuse potential.
• The research will use harmonized behavioral economics methods to quantify and rank abuse potential, supporting safer drug development and regulatory decisions.
• Labcorp will contribute regulatory study expertise; FDA scientists will analyze data and provide regulatory science expertise.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Labcorp Holdings Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: DC79100) on October 22, 2026, and is solely responsible for the information contained therein.